EP 1087661 A4 20030416 - IL-8 RECEPTOR ANTAGONISTS
Title (en)
IL-8 RECEPTOR ANTAGONISTS
Title (de)
IL-8 REZEPTOR ANTAGONISTEN
Title (fr)
ANTAGONISTES DES RECEPTEURS D'IL-8
Publication
Application
Priority
- US 9913739 W 19990617
- US 8963398 P 19980617
Abstract (en)
[origin: WO9965310A1] This invention relates to novel compounds of Formula (I), and compositions thereof, useful in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).
IPC 1-7
IPC 8 full level
A61K 31/404 (2006.01); A61K 31/416 (2006.01); A61K 31/423 (2006.01); A61K 31/428 (2006.01); A61P 1/02 (2006.01); A61P 9/10 (2006.01); A61P 19/10 (2006.01); A61P 31/12 (2006.01); A61P 31/22 (2006.01); A61P 43/00 (2006.01); C07D 231/56 (2006.01); C07D 261/20 (2006.01); C07D 275/06 (2006.01)
CPC (source: EP)
A61K 31/428 (2013.01); A61P 1/02 (2017.12); A61P 9/10 (2017.12); A61P 19/10 (2017.12); A61P 31/12 (2017.12); A61P 31/22 (2017.12); A61P 43/00 (2017.12); Y02A 50/30 (2017.12)
Citation (search report)
- [PA] WO 9832439 A1 19980730 - SMITHKLINE BEECHAM CORP [US], et al
- [A] WO 9749680 A1 19971231 - SMITHKLINE BEECHAM CORP [US], et al
- [A] WO 9701354 A1 19970116 - GENENTECH INC [US]
- See references of WO 9965310A1
Designated contracting state (EPC)
BE CH DE ES FR GB IT LI NL
DOCDB simple family (publication)
WO 9965310 A1 19991223; CA 2335292 A1 19991223; EP 1087661 A1 20010404; EP 1087661 A4 20030416; JP 2002518300 A 20020625
DOCDB simple family (application)
US 9913739 W 19990617; CA 2335292 A 19990617; EP 99928764 A 19990617; JP 2000554201 A 19990617